glucagon glp 1 Glucagon-like peptide-1 GLP-1 Human (31 a.a.)

The fact that retatrutide has shown weight loss potentially exceeding both CagriSema and tirzepatide suggests that more receptor targets may indeed produce better outcomes

2016 Feb;72(2):30615

The oral disintegrating tablet formulation does not alter these reproductive considerations, and the same precautions apply regardless of the route of administration

I think at this point if the "standard of care" does not include a mandatory RT program (especially for older individuals), the doctors should be sued for malpractice

When I work with patients to encourage weight loss, I first consider any underlying disease processes we need to reduce: A patient with mild hypertension may respond favorably to a 5% weight loss, or even slightly less